Literature DB >> 3989912

Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs.

R Mann, D Baltimore.   

Abstract

By using a retroviral construct derived from Moloney murine leukemia virus and capable of expressing the dominant selectable neo gene, we measured the effects of moving or deleting a sequence (psi) known to be required in cis for the packaging of genomic RNA into virus particles. When psi was at its wild-type position (in SVX virus) near the 5' end of the RNA, the titer of infectious virus production was 5 X 10(6) G-418-resistant CFU per ml. The titer was decreased approximately fivefold when psi was moved, in its proper orientation, to near the 3' end of the virus (SVX-psi C) and was decreased approximately 600-fold when psi was moved, in its proper orientation, into the U3 region of the long terminal repeat. When psi was deleted (SVX-psi-) or inserted in the opposite orientation at either of these two positions, the titer was decreased by 3000-fold relative to SVX. In SVX-psi C, psi was no longer in the intron (as it is in SVX and Moloney murine leukemia virus) but was moved to a region which is only exonic. This resulted in the encapsidation of both spliced and unspliced RNAs, their efficient reverse transcription, and their integration into the genome of an infected cell. A number of proviruses resulting from integration of either spliced or unspliced RNAs were cloned. Four of these clones were subjected to sequence analysis in the region of the splice sites, and it was determined which sites are used by these viruses and also which are used by Moloney murine leukemia virus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989912      PMCID: PMC254810     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

2.  A minimal intron length but no specific internal sequence is required for splicing the large rabbit beta-globin intron.

Authors:  B Wieringa; E Hofer; C Weissmann
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

3.  Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes.

Authors:  R Treisman; S H Orkin; T Maniatis
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

4.  Construction and applications of a highly transmissible murine retrovirus shuttle vector.

Authors:  C L Cepko; B E Roberts; R C Mulligan
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

5.  Unusual splice sites revealed by mutagenic inactivation of an authentic splice site of the rabbit beta-globin gene.

Authors:  B Wieringa; F Meyer; J Reiser; C Weissmann
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

6.  Identification of a sequence likely to be required for avian retroviral packaging.

Authors:  T Pugatsch; D W Stacey
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

7.  cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus.

Authors:  J Sorge; W Ricci; S H Hughes
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

8.  Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent.

Authors:  P Schwartzberg; J Colicelli; S P Goff
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

9.  Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene.

Authors:  S Watanabe; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Synthetic donor and acceptor splice sites function in an RNA polymerase B (II) transcription unit.

Authors:  G Rautmann; H W Matthes; M J Gait; R Breathnach
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  73 in total

1.  An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.

Authors:  J D Banks; B O Kealoha; M L Linial
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.

Authors:  K A Delviks; W S Hu; V K Pathak
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV.

Authors:  C Roy; N Tounekti; M Mougel; J L Darlix; C Paoletti; C Ehresmann; B Ehresmann; J Paoletti
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

4.  A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.

Authors:  F Clavel; J M Orenstein
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.

Authors:  R C Hirsch; D D Loeb; J R Pollack; D Ganem
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences.

Authors:  L Han; J S Yun; T E Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

8.  Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RNA packaging signal complex.

Authors:  Jing Zhou; Rebecca L Bean; Volker M Vogt; Michael Summers
Journal:  J Mol Biol       Date:  2006-10-10       Impact factor: 5.469

10.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.